Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.
Axel MuendleinChristine HeinzleEva Maria BrandtnerAndreas LeihererKathrin GeigerStella GaengerHeinz DrexelTobias DechowThomas DeckerPublished in: Breast cancer research and treatment (2023)
Our study suggests that circulating APOM is significantly linked with reduced mortality in metastatic breast cancer patients.